Older mice with flu helped with nanoparticle therapy

Findings could eventually translate to therapeutics to improve outcomes from respiratory illness in people.

10:20 AM

Author | Kelly Malcom

lungs drawing yellow blue lab note
Jacob Dwyer, Justine Ross, Michigan Medicine

Older people are at increased risk from acute respiratory viral infections including SARS-COV-2, the virus that causes COVID-19, and influenza virus. There is an urgent need to identify novel therapeutics to improve outcomes during acute respiratory viral infections with aging.

In a study published in the journal JCI Insight, William Kelley, M.D., Daniel Goldstein, M.D., and their colleagues from the University of Michigan and onCOUR Pharm Inc., employed a mouse model of influenza viral infection to determine whether a proprietary nanoparticle improves outcomes to infection in aged mice.

Prior studies have shown that the nanoparticles used in the study have beneficial effects by preventing damaging immune cells, specifically monocytes, from entering sites of inflammation. Yet the efficacy of these nanoparticles in improving outcomes to viral infection with aging have not been determined previously.

The team used a murine model in which aged mice are highly susceptible to influenza infection. Importantly, as most humans present to clinics after influenza infection, they administered the nanoparticles to aged mice at day three post infection, when the inflammatory response to the infection was well under way.

Kelly and colleagues found that the nanoparticles improved outcomes to influenza infection in aged mice, specifically improving blood oxygenation, reducing lung damage and other clinical outcomes. These clinical findings were associated with a reduced number of tissue-damaging inflammatory monocytes in the lungs of aged mice during infection.

"If these findings can be translated to humans, it could represent a novel therapy to improve outcomes in older people infected with acute respiratory viruses," said Goldstein.

Paper cited: "Nanoparticles reduce monocytes within the lungs to improve outcomes after influenza virus infection in aged mice," JCI InsightDOI: 10.1172/jci.insight.156320

More Articles About: Lab Notes Lung Function Flu All Research Topics Lungs and Breathing
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories person holding arm with band aid teal shirt
Health Lab
More hospitals than ever require staff to get flu shots
Flu vaccination mandates for hospital staff have increased in recent years, especially at hospitals serving veterans
woman laying on floating cell maroon
Health Lab
Circadian rhythm drives the release of important immune cells
A study shows circadian rhythm drives the release of important immune cells in the body.
woman smiling with white short hair and earrings dark with orange background
Health Lab
Using biologic injections for severe asthma after COVID
Biologic injections end up being the best treatment for treating severe asthma after having COVID for one patient.
cancer cell blue yellow
Health Lab
Accessibility issues in cancer care
Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their first phone call to a clinic.
stethoscope blue yellow
Health Lab
New drug could help those with CAH reduce the use of corticosteroids
Michigan Medicine researchers discover that a new drug could help those with CAH, or congenital adrenal hyperplasia, reduce the use of corticosteroids. 
orange background, blue skull, brain maze inside large brain and person with white coat looking at it with a magnifying glass
Health Lab
Uncovering mysteries of the developing brain
The ABCD study, a long-term study of the brains of thousands of young people from preteen to late teen years, is revealing important insights into behavior and mental health.